| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgment to Referees
|
|
|
2015
|
10 |
4 |
p. 449-451
|
artikel
|
| 2 |
A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
|
Shi, Yi
|
|
2015
|
10 |
4 |
p. 565-573
|
artikel
|
| 3 |
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
|
Young, Natalie R.
|
|
2014
|
10 |
4 |
p. 501-508
|
artikel
|
| 4 |
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
|
Young, Natalie R.
|
|
|
10 |
4 |
p. 501-508
|
artikel
|
| 5 |
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
|
Zhao, Yue
|
|
2015
|
10 |
4 |
p. 535-548
|
artikel
|
| 6 |
Aptamer-Functionalized Nanoparticles as “Smart Bombs”: The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment
|
Benedetto, Gregory
|
|
2015
|
10 |
4 |
p. 467-485
|
artikel
|
| 7 |
A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma
|
Penter, Livius
|
|
2015
|
10 |
4 |
p. 523-533
|
artikel
|
| 8 |
Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study
|
Kubackova, Katerina
|
|
2015
|
10 |
4 |
p. 557-563
|
artikel
|
| 9 |
Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor
|
Kang, Guhyun
|
|
2015
|
10 |
4 |
p. 597-601
|
artikel
|
| 10 |
Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study
|
Kosty, Michael P.
|
|
2015
|
10 |
4 |
p. 509-516
|
artikel
|
| 11 |
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
|
Despierre, Evelyn
|
|
2015
|
10 |
4 |
p. 583-596
|
artikel
|
| 12 |
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents
|
García-Alfonso, Pilar
|
|
2015
|
10 |
4 |
p. 453-465
|
artikel
|
| 13 |
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
|
Santoni, Matteo
|
|
2015
|
10 |
4 |
p. 517-522
|
artikel
|
| 14 |
Renal Toxicities of Targeted Therapies
|
Abbas, Anum
|
|
2015
|
10 |
4 |
p. 487-499
|
artikel
|
| 15 |
The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study
|
Fiala, Ondrej
|
|
2015
|
10 |
4 |
p. 549-555
|
artikel
|
| 16 |
The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX
|
Wang, Yufeng
|
|
2015
|
10 |
4 |
p. 575-581
|
artikel
|
Tijdschrift beschrijving